Clinical Trial Update: Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Bowman-Birk inhibitor concentrate to prevent cancer in patients with oral leukoplakia. The study is completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lip and Oral Cavity Cancer
• Oral Leukoplakia
• Oropharyngeal Cancer
• Tongue Cancer

Drugs mentioned

• Bowman-Birk Inhibitor Concentrate (Bowman-Birk inhibitor concentrate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lip and Oral Cavity Cancer, Oral Leukoplakia | Phase 2 | Status: COMPLETED | Results posted: 2014-12-19